SBI Securities’s Pyxis Oncology PYXS Stock Holding History

SBI Securities’s Portfolio PYXS Stock Details PYXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.08K	Sell	462 -47	-9%	-$142	﹤0.01%	2829
2026 Q2	$1.53K	Buy	509 +508	+50,800%	+$971	﹤0.01%	2653
2026 Q1	$1	Hold	1	–	–	﹤0.01%	3991
2025 Q4	$1	Sell	1 -1	-50%	-$4	﹤0.01%	4003
2025 Q3	$4	Buy	2 +1	+100%	+$1	﹤0.01%	4121
2025 Q2	$1	Sell	1 -1	-50%	-$1	﹤0.01%	4128
2025 Q1	$2	Hold	2	–	–	﹤0.01%	4096
2024 Q4	$3	Buy	+2	New	+$6	﹤0.01%	4044

Other funds holding PYXS

T3 Companies New York $103M AUM 54.73% 1-Year Est. Return

APW

Aurora Private Wealth Rockaway, New Jersey $159M AUM 18.68% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

First United Bank & Trust Oakland, Maryland $347M AUM 18.04% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Physician Wealth Advisors Midvale, Utah $869M AUM 17.6% 1-Year Est. Return

Mainstream Capital Management Los Angeles, California $170M AUM 21% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

SBI Securities's PYXS Position: Q3 2026 in Review

SBI Securities reduced its Pyxis Oncology (PYXS) stake by 9.2% in Q3 2026, selling an estimated $142 and leaving 462 shares worth $1.08K. The position accounts for ﹤0.01% of the portfolio, ranked #2829.

SBI Securities first reported a position in PYXS in Q4 2024 and has held it in 8 quarters since. The position peaked at $1.53K in Q2 2026. 9 funds tracked by Wall St. Rank hold PYXS as of Q3 2026.

SBI Securities held 462 shares of Pyxis Oncology worth $1.08K as of Q3 2026.
SBI Securities sold 47 Pyxis Oncology shares in Q3 2026, an estimated $142.
Pyxis Oncology made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #2829 holding.
SBI Securities first reported a position in Pyxis Oncology in Q4 2024 and has held it in 8 quarters since.
SBI Securities's Pyxis Oncology position peaked at $1.53K in Q2 2026.
9 funds tracked by Wall St. Rank held Pyxis Oncology as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.